|Bid||0.00 x 800|
|Ask||0.00 x 1400|
|Day's Range||230.78 - 232.45|
|52 Week Range||174.96 - 267.95|
|PE Ratio (TTM)||14.87|
|Earnings Date||Jul 25, 2018|
|Forward Dividend & Yield||3.00 (1.33%)|
|1y Target Est||283.94|
Yahoo Finance Editor-in-Chief Andy Serwer sits down with Warren Buffet to talk about his healthcare initiative with J.P. Morgan and Amazon.
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
LONDON, UK / ACCESSWIRE / May 11, 2018 / If you want access to our free earnings report on Anthem, Inc. (NYSE: ANTM), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ANTM. Additionally, the Company provided guidance for FY18. Active-Investors.com is currently working on the research report for Cigna Corporation (NYSE: CI), which also belongs to the Healthcare sector as the Company Anthem.
Ben Wolin, Chairman of the Board, said, "We are pleased to welcome Brian to the Diplomat team at this important time, and are confident that his dynamic skillset and significant industry experience make him ideally suited to assume the roles of CEO and Chairman. Brian is a proven healthcare executive having served in various leadership roles for many years, including at Express Scripts, Empire BlueCross BlueShield and Anthem, most recently launching its PBM organization.
Anthem, Inc. (ANTM) announced today that Deepti Jain will lead IngenioRx, Anthem’s newly launched pharmacy benefits manager (PBM). Ms. Jain, who is Chief Operating Officer of IngenioRx, has been directly responsible for the development and operational plan for the company, which will deliver a transformative PBM offering with best-in-class capabilities to improve outcomes and reduce cost of care. “Deepti is a strong leader with more than 20 years of PBM experience and has been responsible for all aspects of the IngenioRx launch and transition plans to date,” said Gail K. Boudreaux, President and CEO, Anthem.
Experts have pointed to the Justice Department's review of AT&T's acquisition of Time Warner as an example of the scrutiny Cigna and Express Scripts could face.
LONDON, UK / ACCESSWIRE / April 30, 2018 / Active-Investors.com has just released a free earnings report on UnitedHealth Group Inc. (NYSE: UNH) ("UNH"). The Company reported its financial results on April 17, 2018, for the first quarter of the fiscal year 2018, ended March 31, 2018. The Company demonstrated strong, broad-based performance in Q1 FY18, with strong improvements in membership growth, revenues, and earnings.
Anthem (ANTM), which is an American health insurance company, was the S&P 500’s second-best performer on April 25. After regaining strength last week, Anthem started this week on a stable note. On April 25, Anthem opened the day higher and surged to 11-week high price levels.
Dr. Pepper Snapple, Anthem, Google and AMC are the companies to watch.
UnitedHealth Group (UNH) stock recorded a rise of ~3.5% on April 17, as the company posted strong 1Q18 results. On April 19, UNH stock closed at $235.76 per share. The company beat analysts’ estimates for its sales, earnings, and profit estimates and raised its fiscal 2018 outlook. UNH stock is trading higher than its 50-day moving average of $224.87 and its 200-day moving average of $220.79.
UnitedHealth Group (UNH), the world’s largest healthcare company by revenue, reported its fiscal 1Q18 earnings results on April 17, 2018. The company’s sales and earnings results exceeded Wall Street analysts’ estimates.
NEW YORK, NY / ACCESSWIRE / April 25, 2018 / Anthem, Inc. (NYSE: ANTM ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 25, 2018 at 8:30 AM Eastern Time. To listen ...
Anthem, Inc. reported strong first quarter 2018 financial results and improved margins while continuing to make strategic investments in growth initiatives.